European Healthtech startup funding raised during January 2024.
In January 2024, 39 European Healthtech companies raised a combined €423M across 39 funding rounds, down 21.2% versus January 2023. Switzerland led by capital raised, and BOM was the most active investor. Data as of 9 Jul 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Timeline | Series D+ | Jan 2024 | €61M |
| Infinite Roots (Mushlabs) | Series B | Jan 2024 | €53M |
| Enterprise Therapeutics | Series B | Jan 2024 | €30M |
| Aqemia | Series A |
| Acquisition |
| Jan 2024 |
| €425M |
| Apotea | Acquisition | Jan 2024 | €12M |
| Jan 2024 |
| €30M |
| Onera Health | Series C | Jan 2024 | €30M |
| icotec | Growth/Late | Jan 2024 | €28M |
| LEM Surgical | Series B | Jan 2024 | €24M |
| Kinvent | Other | Jan 2024 | €16M |
| IMU Biosciences | Series A | Jan 2024 | €13M |
| Enifer | Grant | Jan 2024 | €12M |
| CardioMech | Other | Jan 2024 | €12M |
| Sano Genetics | Other | Jan 2024 | €11M |
| myo | Other | Jan 2024 | €11M |
| Resalis Therapeutics | Series A | Jan 2024 | €10M |
| Qumea | Series A | Jan 2024 | €9.6M |